These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 29441984)

  • 41. Prescribers' views and experiences of using direct acting oral anticoagulants in the management of nonvalvular atrial fibrillation: A survey in remote and rural Scotland.
    Generalova D; Cunningham S; Leslie SJ; Rushworth G; McIver L; Stewart D
    Br J Clin Pharmacol; 2019 Oct; 85(10):2414-2422. PubMed ID: 31313317
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study.
    Abraham NS; Noseworthy PA; Yao X; Sangaralingham LR; Shah ND
    Gastroenterology; 2017 Apr; 152(5):1014-1022.e1. PubMed ID: 28043907
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China.
    Yang X; Li Z; Zhao X; Wang C; Liu L; Wang C; Pan Y; Li H; Wang D; Hart RG; Wang Y; Wang Y;
    Stroke; 2016 Feb; 47(2):464-70. PubMed ID: 26696643
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of Direct Oral Anticoagulants Utilization for Thromboembolism Prevention in Atrial Fibrillation.
    Brais C; Larochelle J; Turgeon MH; Blais L; Farand P; Perreault S; Letemplier G; Beauchesne MF
    J Pharm Pharm Sci; 2017; 20():8-14. PubMed ID: 28459661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW; Barillari G
    J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical trials with direct oral anticoagulants for stroke prevention in atrial fibrillation: how representative are they for real life patients?
    Desmaele S; Steurbaut S; Cornu P; Brouns R; Dupont AG
    Eur J Clin Pharmacol; 2016 Sep; 72(9):1125-34. PubMed ID: 27272167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The prescription of direct oral anticoagulants in the elderly: An observational study of 19 798 Ambulatory subjects.
    Barben J; Menu D; Rosay C; Vovelle J; Mihai AM; Nuss V; d'Athis P; Putot A; Manckoundia P
    Int J Clin Pract; 2020 Jan; 74(1):e13420. PubMed ID: 31532052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding: Characteristics, Reversal Strategies, and Outcomes From a Multicenter Observational Study.
    Xu Y; Schulman S; Dowlatshahi D; Holbrook AM; Simpson CS; Shepherd LE; Wells PS; Giulivi A; Gomes T; Mamdani M; Khuu W; Frymire E; Johnson AP;
    Chest; 2017 Jul; 152(1):81-91. PubMed ID: 28219635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Uptake of Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation in a Single Clinical Commissioning Group in England Without Restrictions to Their Use.
    Medlinskiene K; Fay M; Petty D
    Clin Drug Investig; 2019 Apr; 39(4):401-405. PubMed ID: 30805790
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anticoagulant Initiation During Hospital Admissions for Atrial Fibrillation in South-East Queensland, Australia.
    Rathinam I; Anoopkumar-Dukie S; Badrick T; Teasdale T; Bernaitis N
    Heart Lung Circ; 2020 Sep; 29(9):e222-e230. PubMed ID: 32291155
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.
    Becattini C; Vedovati MC; Agnelli G
    Thromb Res; 2012 Mar; 129(3):392-400. PubMed ID: 22264937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation.
    Admassie E; Chalmers L; Bereznicki LR
    Am J Cardiol; 2017 Oct; 120(7):1133-1138. PubMed ID: 28781025
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Managing the perioperative patient on direct oral anticoagulants.
    Leitch J; van Vlymen J
    Can J Anaesth; 2017 Jun; 64(6):656-672. PubMed ID: 28429198
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis.
    Choudhry NK; Anderson GM; Laupacis A; Ross-Degnan D; Normand SL; Soumerai SB
    BMJ; 2006 Jan; 332(7534):141-5. PubMed ID: 16403771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Clinical Practice: Focus on Rivaroxaban in Stroke Prevention in Patients With Atrial Fibrillation.
    Sanmartín-Fernández M; Marzal-Martín D
    Clin Appl Thromb Hemost; 2017 Oct; 23(7):711-724. PubMed ID: 27624737
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Direct oral anticoagulants: a practical guide for the emergency physician.
    Hogg K; Panag A; Worster A; Thachil J
    Eur J Emerg Med; 2016 Oct; 23(5):330-6. PubMed ID: 27116543
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [New direct oral oral anticoagulants (DOACs) - indications of DOACs].
    Darius H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2014 Mar; 49(3):182-90; quiz 191. PubMed ID: 24711238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Target-specific oral anticoagulants: practice issues for the clinician.
    Plitt A; Giugliano RP
    Hosp Pract (1995); 2014 Aug; 42(3):48-61. PubMed ID: 25255406
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of direct oral anticoagulants during pregnancy; a systematic literature review.
    Lameijer H; Aalberts JJJ; van Veldhuisen DJ; Meijer K; Pieper PG
    Thromb Res; 2018 Sep; 169():123-127. PubMed ID: 30036784
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life.
    Becattini C; Franco L; Beyer-Westendorf J; Masotti L; Nitti C; Vanni S; Manina G; Cattinelli S; Cappelli R; Sbrojavacca R; Pomero F; Marten S; Agnelli G
    Int J Cardiol; 2017 Jan; 227():261-266. PubMed ID: 27843050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.